APA

Pishvaian M. J., Slack R., Koh E. Y., Beumer J. H., Hartley M. L., Cotarla I., Deeken J., He A. R., Hwang J., Malik S., Firozvi K., Liu M., Elston B., Strychor S., Egorin M. J. & Marshall J. L. (20130124). A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. : Cancer chemotherapy and pharmacology.

Chicago

Pishvaian Michael J, Slack Rebecca, Koh Eunice Y, Beumer Jan H, Hartley Marion L, Cotarla Ion, Deeken John, He Aiwu Ruth, Hwang Jimmy, Malik Shakun, Firozvi Kashif, Liu Minetta, Elston Beth, Strychor Sandy, Egorin Merrill J and Marshall John L. 20130124. A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. : Cancer chemotherapy and pharmacology.

Harvard

Pishvaian M. J., Slack R., Koh E. Y., Beumer J. H., Hartley M. L., Cotarla I., Deeken J., He A. R., Hwang J., Malik S., Firozvi K., Liu M., Elston B., Strychor S., Egorin M. J. and Marshall J. L. (20130124). A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. : Cancer chemotherapy and pharmacology.

MLA

Pishvaian Michael J, Slack Rebecca, Koh Eunice Y, Beumer Jan H, Hartley Marion L, Cotarla Ion, Deeken John, He Aiwu Ruth, Hwang Jimmy, Malik Shakun, Firozvi Kashif, Liu Minetta, Elston Beth, Strychor Sandy, Egorin Merrill J and Marshall John L. A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. : Cancer chemotherapy and pharmacology. 20130124.